[Vaccines and preventive activities in patients with inflammatory arthritis]

Semergen. 2013 Oct;39(7):382-5. doi: 10.1016/j.semerg.2013.01.008. Epub 2013 Mar 20.
[Article in Spanish]

Abstract

Patients with inflammatory arthritis and eligible for immunosuppressive therapy account for more than 1% of general population, and represents a significant workload on family doctors. They are prone to other comorbidities, with an increased cardiovascular risk and a higher incidence of infections than the general population, especially skin infections and pneumonitis. This comorbidity can be considered vulnerable to a prevention program-prevention of cardiovascular risk, cancer screening, vaccination schedule for adults. As for prevention through vaccination, importance should be given to pneumococcal infection - significant in adults aged 50 or over, especially amongst immunosuppressed patients. The 13-valent conjugate vaccine, which has been recently approved for adults, must be considered. An attempt has been made to write a simple, applicable document on preventive measures that should be implemented both at primary and secondary care level for those adults.

Keywords: Arthritis; Artritis; Factores de riesgo; Immunization programs; Prevención primaria; Primary prevention; Programas de inmunización; Risk factors; Vaccines; Vacunas.

MeSH terms

  • Arthritis
  • Cardiovascular Diseases
  • Humans
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Vaccines*
  • Risk Factors
  • Streptococcus pneumoniae*
  • Vaccination

Substances

  • Pneumococcal Vaccines